212 related articles for article (PubMed ID: 34716476)
1. Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions.
Wang Y; Li G; Yan K; Fan Z; Long R; Shan J; Dai Y; Wu W
Eur Radiol; 2022 Mar; 32(3):2060-2069. PubMed ID: 34716476
[TBL] [Abstract][Full Text] [Related]
2. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
Wang L; Nie F; Dong T; Yin C; Li M; Li Y
Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
[TBL] [Abstract][Full Text] [Related]
3. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
4. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Solid Pseudopapillary Tumors of the Pancreas: Imaging Findings Compared With Contrast-Enhanced Computed Tomography.
Xu M; Li XJ; Zhang XE; Pan FS; Tan Y; Huang TY; Hong Y; Huang GL; Xie XY
J Ultrasound Med; 2019 Dec; 38(12):3247-3255. PubMed ID: 31179567
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of Contrast-Enhanced Ultrasound Enhancement Patterns for Differentiating Focal Pancreatitis From Pancreatic Carcinoma: A Comparison Study With Conventional Ultrasound.
Wang Y; Yan K; Fan Z; Ding K; Yin S; Dai Y; Yang W; Wu W
J Ultrasound Med; 2018 Mar; 37(3):551-559. PubMed ID: 28850742
[TBL] [Abstract][Full Text] [Related]
6. Role of contrast-enhanced ultrasound with time-intensity curve analysis for differentiating hypovascular solid pancreatic lesions.
Wang L; Nie F; Dong T; Li M; Li Y; Yin C
Eur Radiol; 2023 Jul; 33(7):4885-4894. PubMed ID: 36725721
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses.
Jia WY; Gui Y; Chen XQ; Zhang XQ; Zhang JH; Dai MH; Guo JC; Chang XY; Tan L; Bai CM; Cheng YJ; Li JC; Lv K; Jiang YX
Eur Radiol; 2022 Dec; 32(12):8485-8496. PubMed ID: 35699767
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
10. Transabdominal contrast-enhanced ultrasonography of pancreatic cancer.
Kersting S; Roth J; Bunk A
Pancreatology; 2011; 11 Suppl 2():20-7. PubMed ID: 21464583
[TBL] [Abstract][Full Text] [Related]
11. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound for diagnosing, staging and assessment of operability of pancreatic cancer.
Grossjohann HS
Dan Med J; 2012 Dec; 59(12):B4536. PubMed ID: 23290292
[TBL] [Abstract][Full Text] [Related]
13. Application of Contrast-Enhanced Ultrasound in Cystic Pancreatic Lesions Using a Simplified Classification Diagnostic Criterion.
Fan Z; Yan K; Wang Y; Qiu J; Wu W; Yang L; Chen M
Biomed Res Int; 2015; 2015():974621. PubMed ID: 26090467
[TBL] [Abstract][Full Text] [Related]
14. Activity-Based Cost Analysis of Including Contrast-Enhanced Ultrasound (CEUS) in the Diagnostic Pathway of Focal Pancreatic Lesions Detected by Abdominal Ultrasound.
Faccioli N; Dietrich CF; Foti G; Santi E; Comai A; D'Onofrio M
Ultraschall Med; 2019 Oct; 40(5):618-624. PubMed ID: 30895585
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study.
Gupta P; Rana P; Marodia Y; Samanta J; Sharma V; Sinha SK; Singh H; Gupta V; Yadav TD; Sreenivasan R; Vaiphei K; Rajwanshi A; Kochhar R; Sandhu M
Eur Radiol; 2022 Oct; 32(10):6668-6677. PubMed ID: 35587829
[TBL] [Abstract][Full Text] [Related]
16. The value of contrast-enhanced ultrasound in the characterization of vascular pattern of solid pancreatic lesions.
Ardelean M; Sirli R; Sporea I; Bota S; Danila M; Popescu A; Timar B; Buzas R; Mazilu O; Ardelean O; Lighezan D
Med Ultrason; 2015 Mar; 17(1):16-21. PubMed ID: 25745652
[TBL] [Abstract][Full Text] [Related]
17. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
Quaia E
Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound diagnosis of pancreatic solid tumors.
Sofuni A; Tsuchiya T; Itoi T
J Med Ultrason (2001); 2020 Jul; 47(3):359-376. PubMed ID: 31420821
[TBL] [Abstract][Full Text] [Related]
19. Enhancement patterns in the venous phase of contrast-enhanced ultrasounds: diagnostic value for patients with solid pancreatic lesions.
Chen X; Hao F; Gui Y; Zhang J; Tan L; Xiao M; Zhang Q; Meng H; Li J; Jiang Y; Lv K
Quant Imaging Med Surg; 2021 Oct; 11(10):4321-4333. PubMed ID: 34603987
[TBL] [Abstract][Full Text] [Related]
20. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal masses and risk stratification of cystic renal lesions.
Elbanna KY; Jang HJ; Kim TK; Khalili K; Guimarães LS; Atri M
Eur Radiol; 2021 Nov; 31(11):8468-8477. PubMed ID: 33912992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
